S2: Integrated Testing and Safety Assessment Applications

Session 2 Chair Barry Hardy

Session 2 Chair Barry Hardy, OpenTox Asia 2018
PRESENTING AUTHOR: 
Barry Hardy
CHAIR PROFILE: 

Dr Barry J. Hardy is leading Douglas Connect and its team supporting the development of new integrating solutions in industrial safety assessment.

SESSION DESCRIPTION: 

To make a good decision we need to bring both expertise and relevant information together to form the basis for a structured well-informed discussion leading to best judgement based on available evidence and opinions formed on it.

S2: Development of an artificial neural network model for risk assessment

Development of an artificial neural network model for risk assessment, Morihiko Hirota , OpenTox Asia 2018
PRESENTING AUTHOR: 
Morihiko Hirota
ABSTRACT CONTENT / DETAILS: 

In the safety assessment of cosmetic ingredients, the importance of both in vitro and in silico tests has increased since 2013. In the field of skin sensitization, three in vitro methods, the direct peptide reactivity assay (DPRA), KeratinoSens™, and the human Cell Line Activation Test (h-CLAT), were adopted under OECD guidelines.

Pages